Research Wire

A cost-effective screening tool developed by WashU Medicine researchers allows for broader genomic testing for patients with peripheral neuropathy of unknown cause.

WashU Medicine researchers at the Bright Center for Human Vision have developed gene therapies that help retinal cells clear toxic proteins in mouse and human models of retinitis pigmentosa, an inherited degenerative condition that causes blindness.

A grant of nearly $800,000 will fund the development of an “AI Scientist” system aimed at improving biomedical research efficiency, with an initial focus on neurodegenerative disease.

WashU Medicine researchers led by Ryan Raut show that it is possible to accurately predict the state of brain activity by tracking variations in an animal’s pupil dilation, suggesting that brain circuits and the body are more dynamic and interrelated than previously thought.

A study led by WashU Medicine researchers reveals molecular insights into Alzheimer’s disease, Parkinson’s disease and other dementias that could lead to earlier, more precise diagnoses.

WashU Arts & Sciences researchers clarify when complexity enables prediction in microbial systems.

Researchers at WashU have won $2.7 million from the National Institutes of Health (NIH) for a five-year investigation into the power of sleep to prevent, delay and diminish Alzheimer’s and other neurodegenerative diseases.

Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.

A study by WashU Medicine researchers offers new insight into how environmental factors protect against opioid addiction and support recovery.

Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.